Corona Remedies
add_icon

Corona Remedies

1,948.60
+33.70
(1.76%)
Market Cap
11,917.65 Cr
PE Ratio
63.23
Volume
1,90,906.00
Day High - Low
2,023.00 - 1,920.00
52W High-Low
2,100.70 - 1,336.60
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
11,917.65 Cr
EPS
30.27
PE Ratio
63.23
PB Ratio
15.67
Book Value
122.12
EBITDA
304.10
Dividend Yield
0.52 %
Industry
Healthcare
Return on Equity
24.79
Debt to Equity
0.19
Analyst Rating and Forecast
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Sepia Investments Limited and partners sold 4.58 million shares in Corona Remedies Limited on June 17, 2026, reducing their combined holding.
neutral
Corona Remedies filed its Business Responsibility and Sustainability Report for FY 2025-26, detailing ESG initiatives and compliance.
neutral
Corona Remedies Limited has scheduled its 22nd Annual General Meeting for July 9, 2026, via video conferencing. The company has fixed June 19, 2026, as the record date for dividend entitlement.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,874.40
#1 4,49,731.35
38.94
#1 58,220.10
6.38
#1 11,565
25.80
66.93
6,753.50
1,79,284.21
69.71
10,560.00
8.73
2,520
13.44
55.02
4,504.40
1,52,449.36
71.45
13,886.20
20.34
2,138
-26.91
55.98
1,437.90
1,16,150.78
29.98
29,044.60
2.24
3,870
-55.32
65.05
1,328.40
1,10,873.98
26.13
33,593.30
-0.44
3,998
-86.05
64.53
1,099.30
1,10,615.30
21.84
26,719.70
13.65
5,242
7.82
61.12
2,367.60
1,08,209.55
#1 20.12
27,487.50
19.98
5,345
#1 87.72
63.99
2,483.00
1,02,499.50
53.90
14,277.60
12.03
1,750
31.75
59.95
1,530.60
88,897.50
25.46
33,384.70
3.21
3,376
1.99
63.83
1,454.20
78,505.94
89.85
6,867.80
#1 22.01
890
21.18
65.69
Growth Rate
Revenue Growth
17.58 %
Net Income Growth
23.90 %
Cash Flow Change
20.47 %
ROE
0.61 %
ROCE
-3.27 %
EBITDA Margin (Avg.)
5.18 %

Quarterly Financial Results

Quarterly Financials
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
293
316
299
295
349
364
345
358
Expenses
242
247
228
240
277
283
278
291
EBITDA
51
69
70
56
72
81
66
66
Operating Profit %
17 %
21 %
23 %
18 %
20 %
22 %
19 %
18 %
Depreciation
8
9
10
10
9
9
9
10
Interest
3
3
2
2
2
2
2
1
Profit Before Tax
39
57
58
44
61
70
55
55
Tax
9
14
13
12
15
18
14
9
Net Profit
30
43
45
32
46
52
41
45
EPS in ₹
4.90
7.03
7.35
5.16
7.55
8.55
6.75
7.41

Balance Sheet

Balance Sheet
2023
2024
2025
2026
Total Assets
595
831
930
1,205
Fixed Assets
185
384
370
554
Current Assets
292
290
339
348
Capital Work in Progress
65
121
186
143
Investments
32
26
26
26
Other Assets
314
301
348
482
Total Equity & Liabilities
595
831
930
1,205
Current Liabilities
137
224
240
361
Non Current Liabilities
49
126
84
97
Total Equity
409
480
606
747
Reserve & Surplus
347
419
545
686
Share Capital
61
61
61
61

Cash Flow

Cash Flow
2023
2024
2025
2026
Net Cash Flow
8
-11
0
-1
Investing Activities
-50
-267
-84
-256
Operating Activities
103
157
191
230
Financing Activities
-45
99
-107
25

Share Holding

% Holding
Apr 2025
Dec 2025
Mar 2026
Promoter
72.50 %
69.00 %
69.00 %
FIIs
0.00 %
1.84 %
2.25 %
DIIs
0.00 %
6.76 %
7.02 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
1.36 %
0.77 %
Others
27.50 %
21.05 %
20.97 %
No of Share Holders
9
9
19,609

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.31 10
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.47 0.52

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
09 Jul 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
09 Jul 2026 1,728.40 1,914.90
02 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
02 Jan 2026 1,347.70 1,402.95
02 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
02 Feb 2026 1,404.80 1,447.75
11 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 May 2026 1,689.20 1,712.15
19 Jun 2026 DIVIDEND Dividend
₹ 10.00 /share
19 Jun 2026 1,712.15 1,832.65

Announcements

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20115 days ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20115 days ago
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 20115 days ago
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 20115 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication8 days ago
Reg. 34 (1) Annual Report.8 days ago
Communication To Shareholders8 days ago
Business Responsibility and Sustainability Reporting (BRSR)8 days ago
Regulation 34(1)-Annual Report8 days ago
Notice Of 22Nd Annual General Meeting8 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 03, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 01, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 28, 2026
General-UpdatesMay 21, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 19, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 18, 2026
Annual Secretarial Compliance Report For The Financial Year Ended March 31 2026May 12, 2026
Annual Secretarial Compliance Report For The Financial Year Ended March 31 2026May 12, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 12, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 12, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 11, 2026
Record Date For The Purpose Of Final Dividend For The F.Y. 2025-26 Is June 19 2026May 11, 2026
Corporate Action-Board approves DividendMay 11, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 11, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 11, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 11, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 11, 2026
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sMay 11, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 11, 2026
Financial Results For The Fourth Quarter And Year Ended March 31 2026May 11, 2026
Board Meeting Outcome for Outcome Of Board MeetingMay 11, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 30, 2026
Board Meeting Intimation for Consideration And Approval Of Audited Financial Results On Standalone And Consolidated Basis For The Fourth Quarter And Year Ended On March 31 2026 Apr 30, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 30, 2026
Closure of Trading WindowMar 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 07, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 17, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 03, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 03, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 02, 2026
Announcement under Regulation 30 (LODR)-Credit RatingFeb 02, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 02, 2026
Financial Results For The Third Quarter And Nine Months Ended December 31 2025Feb 02, 2026
Board Meeting Outcome for Outcome Of Board MeetingFeb 02, 2026
Intimation Of Violation Under The Companys Code Of Conduct For Regulating Monitoring And Reporting Of Insider Trading In Securities And The SEBI (Prohibition Of Insider Trading) Regulations 2015Jan 30, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
2.06%
0
0.00%
-0.18%
Angel One Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Axis Business Cycles Fund Direct-Growth
0.64%
0
0.00%
-0.02%
Axis Equity Savings Fund Direct-Growth
0.77%
0
0.00%
-0.02%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.05%
0
0.00%
0.00%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
DSP Healthcare Fund Direct-Growth
0.00%
0
0.00%
-0.15%
Edelweiss Recently Listed IPO Fund Direct-Growth
1.84%
0
0.00%
-0.09%
Franklin India Large & Mid Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Groww Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
HDFC Pharma And Healthcare Fund Direct-Growth
0.00%
0
0.00%
0.00%
ICICI Prudential Quality Fund Direct-Growth
0.00%
0
0.00%
-0.11%
Invesco India Consumption Fund Direct-Growth
2.43%
0
-0.09%
-0.08%
Invesco India ELSS Tax Saver Fund Direct-Growth
0.64%
0
0.00%
-0.01%
Invesco India Large & Mid Cap Fund Direct-Growth
0.41%
0
0.00%
-0.03%
Invesco India Mid Cap Fund Direct-Growth
0.95%
0
0.00%
-0.08%
Invesco India Multicap Fund Direct-Growth
1.15%
0
0.00%
-0.06%
Invesco India Smallcap Fund Direct-Growth
2.00%
0
0.00%
-0.19%
Kotak Consumption Fund Direct-Growth
0.59%
0
0.00%
-0.01%
Kotak Healthcare Fund Direct-Growth
1.65%
0
0.00%
-0.26%
Mirae Asset Healthcare Fund Direct-Growth
0.00%
0
0.00%
0.00%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Motilal Oswal Nifty Microcap 250 Index Fund Direct-Growth
0.09%
0
0.00%
0.00%
SBI Healthcare Opportunities Fund Direct Plan-Growth
0.00%
0
0.00%
0.00%
Tata India Pharma & Healthcare Fund Direct-Growth
0.45%
0
0.00%
-0.32%

Technical Indicators

RSI(14)
Neutral
69.86
ATR(14)
Volatile
80.77
STOCH(9,6)
Neutral
47.03
STOCH RSI(14)
Overbought
94.01
MACD(12,26)
Bullish
17.33
ADX(14)
Strong Trend
37.68
UO(9)
Bearish
36.99
ROC(12)
Uptrend And Accelerating
11.01
WillR(14)
Neutral
-41.98